150 related articles for article (PubMed ID: 24512318)
1. Left behind: should minimal residual disease be treated in hairy cell leukemia?
Park JH; Tallman MS
Leuk Lymphoma; 2014 May; 55(5):971-2. PubMed ID: 24512318
[No Abstract] [Full Text] [Related]
2. [Hairy cell leukemia and its treatment with 2-chlorodeoxyadenosine (2-CdA)].
Pawelski S
Acta Haematol Pol; 1995; 26(2):139-43. PubMed ID: 7653218
[TBL] [Abstract][Full Text] [Related]
3. Newer purine analogues for the treatment of hairy-cell leukemia.
Saven A; Piro L
N Engl J Med; 1994 Mar; 330(10):691-7. PubMed ID: 7906385
[No Abstract] [Full Text] [Related]
4. Cross-resistance to purine analogs in hairy cell leukemia.
Kraut EH
Ann Intern Med; 1994 Feb; 120(3):247-8. PubMed ID: 7506014
[No Abstract] [Full Text] [Related]
5. [Hairy cell leukemia--a potentially curable malignancy. Selected aspects of purine analog therapy].
Rucińska M; Machaczka M; Załuska A; Skotnicki AB
Przegl Lek; 1998; 55(7-8):400-6. PubMed ID: 10021885
[TBL] [Abstract][Full Text] [Related]
6. Pentostatin: impact on outcome in hairy cell leukemia.
Grever MR
Hematol Oncol Clin North Am; 2006 Oct; 20(5):1099-108. PubMed ID: 16990110
[TBL] [Abstract][Full Text] [Related]
7. Risk of additional cancers in untreated and treated hairy cell leukemia patients.
Dasanu CA; Alexandrescu DT
Expert Opin Pharmacother; 2010 Jan; 11(1):41-50. PubMed ID: 20001428
[TBL] [Abstract][Full Text] [Related]
8. Hairy cell leukemia: treatment successes in the past 25 years.
Golomb HM
J Clin Oncol; 2008 Jun; 26(16):2607-9. PubMed ID: 18509168
[No Abstract] [Full Text] [Related]
9. Rituximab with pentostatin or cladribine: an effective combination treatment for hairy cell leukemia after disease recurrence.
Else M; Dearden CE; Matutes E; Forconi F; Lauria F; Ahmad H; Kelly S; Liyanage A; Ratnayake V; Shankari J; Whalley I; Catovsky D
Leuk Lymphoma; 2011 Jun; 52 Suppl 2():75-8. PubMed ID: 21504288
[TBL] [Abstract][Full Text] [Related]
10. Long-term results for pentostatin and cladribine treatment of hairy cell leukemia.
Dearden CE; Else M; Catovsky D
Leuk Lymphoma; 2011 Jun; 52 Suppl 2():21-4. PubMed ID: 21599603
[TBL] [Abstract][Full Text] [Related]
11. Hairy-cell leukaemia: first-line treatment with cladribine or pentostatin.
Prescrire Int; 2006 Aug; 15(84):143-4. PubMed ID: 16989031
[TBL] [Abstract][Full Text] [Related]
12. Hairy cell leukemia treated initially with purine analogs: a retrospective study of 107 patients from the Spanish Cooperative Group on Chronic Lymphocytic Leukemia (GELLC).
López Rubio M; Da Silva C; Loscertales J; Seri C; Baltasar P; Colado E; Pérez Fernández I; Osma M; Gomis F; González M; Jarque I; Vargas M; Monzó E; Monteagudo D; Orts MI; Pardal E; Carbonell F; Perez Calvo C; Garcia-Marco JA
Leuk Lymphoma; 2014 May; 55(5):1007-12. PubMed ID: 23885799
[TBL] [Abstract][Full Text] [Related]
13. Cost-effectiveness of pentostatin compared with cladribine in the management of hairy cell leukemia in the United Kingdom.
Guest JF; Smith H; Sladkevicius E; Jackson G
Clin Ther; 2009; 31 Pt 2():2398-415. PubMed ID: 20110049
[TBL] [Abstract][Full Text] [Related]
14. Long remissions in hairy cell leukemia with purine analogs: a report of 219 patients with a median follow-up of 12.5 years.
Else M; Ruchlemer R; Osuji N; Del Giudice I; Matutes E; Woodman A; Wotherspoon A; Swansbury J; Dearden C; Catovsky D
Cancer; 2005 Dec; 104(11):2442-8. PubMed ID: 16245328
[TBL] [Abstract][Full Text] [Related]
15. Do we know the treatment of choice for hairy cell leukemia?
Golomb HM
Ann Oncol; 1994 Oct; 5(8):676-7. PubMed ID: 7826898
[No Abstract] [Full Text] [Related]
16. Pentostatin and 2-chlorodeoxyadenosine for hairy-cell leukemia.
Med Lett Drugs Ther; 1992 Sep; 34(879):89-90. PubMed ID: 1355592
[No Abstract] [Full Text] [Related]
17. Therapeutic advances in the treatment of hairy cell leukemia.
Andrey J; Saven A
Leuk Res; 2001 May; 25(5):361-8. PubMed ID: 11301103
[No Abstract] [Full Text] [Related]
18. Long-Term Outcomes of Hairy Cell Leukemia Treated With Purine Analogs: A Comparison With the General Population.
Madanat YF; Rybicki L; Radivoyevitch T; Jagadeesh D; Dean R; Pohlman B; Kalaycio M; Sekeres MA; Smith MR; Hill BT
Clin Lymphoma Myeloma Leuk; 2017 Dec; 17(12):857-862. PubMed ID: 28778620
[TBL] [Abstract][Full Text] [Related]
19. Long-term outcome following treatment of hairy cell leukemia with pentostatin (Nipent): a National Cancer Institute of Canada study.
Johnston JB; Eisenhauer E; Wainman N; Corbett WE; Zaentz SD; Daeninck PJ
Semin Oncol; 2000 Apr; 27(2 Suppl 5):32-6. PubMed ID: 10877049
[TBL] [Abstract][Full Text] [Related]
20. Chemoimmunotherapy for hairy cell leukemia.
Ravandi F
Best Pract Res Clin Haematol; 2015 Dec; 28(4):230-5. PubMed ID: 26614901
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]